India pins hopes on locally-tested COVID-19 vaccines given Pfizer constraints




  • In US
  • 2020-11-17 13:58:01Z
  • By Reuters
India pins hopes on locally-tested COVID-19 vaccines given Pfizer constraints
India pins hopes on locally-tested COVID-19 vaccines given Pfizer constraints  

By Krishna N. Das

NEW DELHI (Reuters) - India hopes five locally-tested vaccines will help it to control COVID-19, as those developed by Pfizer <PFE.N> and Moderna <MRNA.O> may not be available to it in big quantities soon.

The five candidates include Russia's Sputnik-V whose "Phase-II going to Phase-III" trials in India will start next week in collaboration with Dr Reddy's Laboratories <REDY.NS>, Vinod Paul, the head of a committee advising the prime minister, said.

The other experimental vaccines are the one being developed by AstraZeneca <AZN.L> and Oxford University which is being manufactured by the Serum Institute of India; Bharat Biotech and the Indian government's COVAXIN; Zydus Cadila's ZyCoV-D and lastly one being developed by Biological E. Ltd alongside Baylor College of Medicine and Dynavax Technologies Corp <DVAX.O>.

Paul told a news briefing that AstraZeneca vaccine's last-stage trials in India had gone well and had almost been completed. The country of 1.35 billion people has reported 8.87 million infections, second only to the United States, and 130,519 deaths as a result of COVID-19.

"We are very hopeful that we will be successful with the five vaccines," Paul said on Tuesday. "They are easy platforms, availability of doses is very high. They will be able to control our pandemic in terms of the numbers of doses required."

Paul said the government was also watching the progress of the Pfizer and Moderna vaccines, both of which have said interim results of last-stage trials of their candidates showed that they were more than 90% effective.

Unlike Pfizer's vaccine which must be kept at minus 70 degrees Celsius or below, Moderna's can be stored at normal fridge temperatures, making it more suited for poorer countries such as India where cold chains are limited.

"This obviously will be a very big hindrance to scale up the vaccine," Paul said of Pfizer's, adding that if India finds itself needing to do so it will pursue this option.

"If we are required to form our strategy on this particular vaccine, then we will proceed with it. Though, even if we get it, we will get it in a few months only. But talks are ongoing."


(Reporting by Krishna N. Das; Editing by Alexander Smith)

COMMENTS

More Related News

NYC health official says kids under 18 not yet in line for vaccine
NYC health official says kids under 18 not yet in line for vaccine

NEW YORK - Children under the age of 18 won't receive COVID-19 vaccinations in New York City because there has not been enough testing in that age range, the...

Dutch PM Rutte: expects one million doses of Pfizer, 400,000 doses of Moderna vaccines
Dutch PM Rutte: expects one million doses of Pfizer, 400,000 doses of Moderna vaccines
  • US
  • 2020-12-04 15:18:48Z

The Netherlands' Prime Minister said on Friday that the country expects to receive 1 million doses of Pfizer's vaccine in January, and 400,000 doses of...

Exclusive: FDA chief had
Exclusive: FDA chief had 'robust discussion' with White House about vaccine timelines
  • US
  • 2020-12-04 13:16:21Z

The U.S. Food and Drug Administration's chief had a "robust discussion" with the White House this week about the timeline for coronavirus vaccine approvals...

Trump is reportedly furious with officials because the UK approved a coronavirus vaccine before the US
Trump is reportedly furious with officials because the UK approved a coronavirus vaccine before the US

Trump desperately wants he, not President-elect Joe Biden, to receive credit for the rolling out of a vaccine in the US, according to reports.

UK hopes for millions of Pfizer/BioNTech vaccine doses this year: minister
UK hopes for millions of Pfizer/BioNTech vaccine doses this year: minister
  • US
  • 2020-12-04 07:39:59Z

Britain hopes that millions of doses of the Pfizer/BioNTech COVID-19 vaccine will be delivered by the end of the year but the total will depend on how...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • 먹튀검증
    (2020-11-28 11:42:03Z)

    The post is written in very a good manner and it contains many useful information for me.

    REPLY
  • 대출
    (2020-11-28 11:42:28Z)

    Excellent article. Very interesting to read. I really love to read such a nice article. Thanks! keep rocking.

    REPLY

Top News: US